Immunotherapy With Checkpoint Inhibitors in Patients With Ovarian Cancer: Still Promising?

Cancer - United States
doi 10.1002/cncr.32520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cardiotoxicity of Immune Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Current State and Perspectives of Checkpoint Inhibitors in Ovarian Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer Research
MedicineCancer ResearchOncology
2020English

Palliative Radiotherapy in Advanced Cancer Patients Treated With Immune‑checkpoint Inhibitors: The PRACTICE Study

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

PS4 Clinical Outcomes in Hispanic Patients Treated With Checkpoint Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy